Elion Energy Co Ltd

Elion Energy Co Ltd

Health CarePharmaceuticals & Biotechnology
  • Price (CNY)7.83
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change26.70%
  • Beta1.0081
Data delayed at least 15 minutes.
More ▼

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Elion Energy Co Ltd grew revenues 37.13% from 8.06bn to 11.05bn while net income improved 97.72% from 130.70m to 258.43m.
Gross margin10.57%
Net profit margin3.94%
Operating margin3.72%
Return on assets1.89%
Return on equity2.65%
Return on investment2.98%
More ▼

Cash flow in CNYView more

In 2016, Elion Energy Co Ltd increased its cash reserves by 434.63%, or 2.72bn. Cash Flow from Financing totalled 3.11bn or 28.14% of revenues. In addition the company generated 377.33m in cash from operations while cash used for investing totalled 763.56m.
Cash flow per share--
Price/Cash flow per share--
Book value per share5.06
Tangible book value per share4.38
More ▼

Balance sheet in CNYView more

Elion Energy Co Ltd has a Debt to Total Capital ratio of 38.46%, a higher figure than the previous year's 34.73%.
Current ratio1.64
Quick ratio1.56
Total debt/total equity0.6787
Total debt/total capital0.3846
More ▼

Growth rates in CNY

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 8.11% and 97.73%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)0.53%
Div growth rate (5 year)-7.42%
Payout ratio (TTM)35.74%
EPS growth(5 years)-10.88
EPS (TTM) vs
TTM 1 year ago
More ▼
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.